Correlation Between Microsoft and Regenicin
Can any of the company-specific risk be diversified away by investing in both Microsoft and Regenicin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Regenicin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Regenicin, you can compare the effects of market volatilities on Microsoft and Regenicin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Regenicin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Regenicin.
Diversification Opportunities for Microsoft and Regenicin
Pay attention - limited upside
The 3 months correlation between Microsoft and Regenicin is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Regenicin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regenicin and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Regenicin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regenicin has no effect on the direction of Microsoft i.e., Microsoft and Regenicin go up and down completely randomly.
Pair Corralation between Microsoft and Regenicin
If you would invest 40,862 in Microsoft on September 2, 2024 and sell it today you would earn a total of 1,484 from holding Microsoft or generate 3.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Microsoft vs. Regenicin
Performance |
| Timeline |
| Microsoft |
| Regenicin |
Microsoft and Regenicin Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and Regenicin
The main advantage of trading using opposite Microsoft and Regenicin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Regenicin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenicin will offset losses from the drop in Regenicin's long position.| Microsoft vs. Palo Alto Networks | Microsoft vs. Uipath Inc | Microsoft vs. Block Inc | Microsoft vs. Adobe Systems Incorporated |
| Regenicin vs. Denali Therapeutics | Regenicin vs. Cardiff Oncology | Regenicin vs. Cytodyn | Regenicin vs. Inovio Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |